LATENT AUTOIMMUNE DIABETES IN YOUTH PRESENTING AS YOUNG-ONSET TYPE 2 DIABETES
Citations Over TimeTop 14% of 2025 papers
Abstract
INTRODUCTION/BACKGROUND Latent autoimmune diabetes forms a continuous age-related spectrum from LADY to LADA, where LADY exhibits greater autoimmunity. Latent autoimmune diabetes in youth (LADY) is diagnosed in individuals aged 15 to 29 years. A high prevalence of LADY is observed among youth with the T2DM phenotype. The TCF7L2 rs12255372 polymorphism is linked to an increased risk of developing T2DM at a young age and is associated with lower levels of GADA in individuals with either T2DM or latent autoimmune diabetes. CASE A 28-year-old female with no history of T2DM was admitted to the emergency room due to altered mental status. She had experienced a weight loss of approximately 10 kg and frequent nocturnal urination; however, she had never consulted a physician. Both her parents and her sister have a known history of T2DM. A physical examination revealed excess body weight and acanthosis nigricans. Laboratory results indicated elevated glucose levels, a high A1C level, a normal fasting C-peptide, negative ketones in the urine and a high HOMA-IR score. Following the patient's clinical improvement, we transitioned from insulin to oral hypoglycemic drugs. After several weeks, we identified a positive anti-GAD result and the TCF7L2 gene polymorphism, rs12255372 (G/T). CONCLUSION The clinical diagnosis of latent autoimmune diabetes (LAD) can be quite challenging. Young individuals exhibiting a T2DM phenotype should undergo assessment for pancreatic islet cell autoantibodies. Common TCF7L2 gene polymorphisms are linked to T2DM and latent autoimmune diabetes but not type 1 diabetes.
Related Papers
- GAD65 autoantibody titres at diagnosis in Latent Autoimmune Diabetes in Adults (LADA) differ from Type 1 diabetes (T1D) and together with epitope specificity predict insulin requirement(2004)
- → Autoimmune diabetes mellitus adult patients having latent autoimmune diabetes of adulthood (LADA) form exhibit different prevalence of accompanying autoimmune diseases than patients with conventional (juvenile) autoimmune type 1 diabetes: Furthermore, anti-GAD autoantibodies are strongly associated with accompanying autoimmune diseases in patients with autoimmune diabetes mellitus(2019)1 cited
- → Anti-GAD Antibody in Patients with Adult-Onset Diabetes in Korea(2009)1 cited
- → Diabulimia and Poorer Glycemic Control in Type 1 Diabetes (T1DM) and Latent Autoimmune Diabetes in Adults (LADA) patients(2021)
- → Diabulimia and Poorer Glycemic Control in Type 1 Diabetes (T1DM) and Latent Autoimmune Diabetes in Adults (LADA) patients(2021)